• Asian Pacific Journal of Cancer Prevention
• /
• 제15권10호
• /
• pp.4175-4179
• /
• 2014

Aims: To delineate the histopathological pattern of prostate diseases and to highlight age variations in prostate specific antigen (PSA) values and histopathological features. Materials and Methods: A retrospective review was made of all prostate biopsy reports seen between January 2006 and December 2013 at the King Fahad Hospital, Madinah, Saudi Arabia. Prostate lesions were tabulated and classified into benign and malignant groups. Histological scoring of adenocarcinomas was accomplished using the Gleason system. PSA values were correlated with Gleason scores. Results: Of 417 prostate lesions reviewed, 343 (82.3%) were benign and 74 (17.7%) were malignant, giving a benign to malignant ratio of 4.6:1. Benign prostatic hyperplasia (both with and without inflammation) was the commonest prostatic lesion and accounted for 80.3% of all cases and 97.6% of all benign cases. The age range was 20 to 97 years with a mean of 69.2 years and a peak age group at 70-79 years. Seventy one cases of adenocarcinoma accounted for 95.9% of the total of 74 malignant tumors. It showed an age range of 44 to 95 years, a mean age of 70.9 years and peak prevalence in the 80-89 year age group. Gleason score seven was the most frequent (39.4%) in occurrence. Most adenocarcinomas, 41 cases (57.7%), were moderately differentiated (Gleason score of 5-7). PSA values ranged widely between 16-1,865ng/ml with a mean of 363.4ng/ml. Elevated PSA (>100ng/ml) levels were found in 53 (81.6%) patients. There was a statistically significant positive correlation between serum PSA level and Gleason score (p=0.0304). Conclusions: Prostatic lesions constitute a significant source of morbidity among adult males in Madinah. Benign prostatic hyperplasia was the commonest benign prostatic lesion and adenocarcinoma was the commonest histological subtype of prostatic cancer.

• Journal of Radiation Protection and Research
• /
• 제37권3호
• /
• pp.149-158
• /
• 2012

알파, 베타핵종의 분리측정에 효과적인 저준위 액체섬광계수기를 이용하여 부산 금정구의 10지점을 선정하여 1년 동안 지하수 내 라돈농도의 변화를 측정하였다. 액체섬광계수기의 최적화된 측정방법을 결정하기 위하여 라듐-226의 표준선원을 이용하여 효율과 백그라운드의 관계를 나타내는 FM (Figure of Merit) 값이 최대가 되는 PSA 준위가 100에서 110범위에 있음을 확인하였다. 결정된 PSA 준위에서 측정된 부산 금정구 지역의 각 암석 분포에 대한 지하수 내 라돈의 평균 농도를 비교해보면, 흑운모화강암 지역은 191.39 $Bq{\cdot}L^{-1}$, 미문상화강암 지역은 141.88 $Bq{\cdot}L^{-1}$, 아다멜라이트 지역은 92.94 $Bq{\cdot}L^{-1}$, 안산암 지역은 35.35 $Bq{\cdot}L^{-1}$ 순으로 나타났다. 조사지역의 10개 지점에서 1년간 정기적으로 측정된 라돈농도의 변화 양상을 살펴보면, 뚜렷하게 구분되는 특징적 계절적 변화양상이 나타나지 않고 있다. 지하수 내 라돈 농도와 수온, 기온, 대기압, 강수량의 상관성을 알아본 결과 각각에 대한 뚜렷한 연관성은 찾을 수 없었으며, 하나의 변수에 대해서가 아니라 보다 복합적 요인과 작용에 의해 변화한다고 판단된다.

• Radiation Oncology Journal
• /
• 제32권3호
• /
• pp.179-186
• /
• 2014

Purpose: To study the long-term outcomes and tolerance in our patients who received dose escalated radiotherapy in the early salvage post-prostatectomy setting. Materials and Methods: The medical records of 54 consecutive patients who underwent radical prostatectomy subsequently followed by salvage radiation therapy (SRT) to the prostate bed between 2003-2010 were analyzed. Patients included were required to have a pre-radiation prostate specific antigen level (PSA) of 2 ng/mL or less. The median SRT dose was 70.2 Gy. Biochemical failure after salvage radiation was defined as a PSA level >0.2 ng/mL. Biochemical control and survival endpoints were analyzed using the Kaplan-Meier method. Univariate and multivariate Cox regression analysis were used to identify the potential impact of confounding factors on outcomes. Results: The median pre-SRT PSA was 0.45 ng/mL and the median follow-up time was 71 months. The 4- and 7-year actuarial biochemical control rates were 75.7% and 63.2%, respectively. The actuarial 4- and 7-year distant metastasis-free survival was 93.7% and 87.0%, respectively, and the actuarial 7-year prostate cancer specific survival was 94.9%. Grade 3 late genitourinary toxicity developed in 14 patients (25.9%), while grade 4 late genitourinary toxicity developed in 2 patients (3.7%). Grade 3 late gastrointestinal toxicity developed in 1 patient (1.9%), and grade 4 late gastrointestinal toxicity developed in 1 patient (1.9%). Conclusion: In this series with long-term follow-up, early SRT provided outcomes and toxicity profiles similar to those reported from the three major randomized trials studying adjuvant radiation therapy.

• 한국지하수토양환경학회:학술대회논문집
• /
• 한국지하수토양환경학회 2006년도 총회 및 춘계학술발표회
• /
• pp.319-323
• /
• 2006

파형분석(PSA) 기능과 백그라운드 낮고 계측효율이 높은 장점을 가지고 있는 저준위 액체섬광계수기를 이용하여 지하수중의 $^{222}Rn$ 측정을 위한 최적 분석조건을 확립하였다. 라돈분석을 위해 섬광용액 HiSafe 3 12 ml를 사용하여 물시료 8 ml 내 $^{222}Rn$ 을 측정하였다. 라돈은 딸핵종과의 방사평형을 위해 3시간동안 방치한 후 계측하였다. 최적 파형분석 (PSA) 준위는 100 이었다. $^{222}Rn$의 계측효율은 $^{226}Ra$ 표준시료를 동일 조건으로 제조한 후 약 20일 이상 방치한 다음 측정하여 결정하였으며 측정효율은 약 $91.6{\pm}3.6%$ 이었다. 동일 시료의 라돈 추출실험 재현성은 2 % 이내이었다. 계측시간 10시간을 기준으로 바탕값은 0.035 cpm 이었고 300분 계측시 검출하한값은 0.11 Bq/L 이었다.

• 한국광학회지
• /
• 제33권1호
• /
• pp.11-21
• /
• 2022

본 연구에서는 자율주행차의 라이다 센서용 광위상배열(optical phased array, OPA)에서 우수한 신호 품질을 얻을 수 있는 방법에 대해 조사하였다. OPA를 구성하는 광 안테나가 주기적으로 배치되어 있는 경우에는 grating lobe의 형성으로 인해 빔 조향의 범위가 제한된다. 광 안테나가 비주기적으로 배치된 OPA에서는 한 개의 main lobe만 형성되어 넓은 조향 범위가 가능하지만 side lobe에 의한 잡음의 영향으로 신호 품질이 저하된다. 본 논문에서는 이러한 비주기적인 OPA에서 발생하는 잡음을 최소화하고 신호 품질을 향상시키기 위한 최적화 연구를 수행한 결과를 보고한다. 최적화를 위한 목적 함수로는 side-lobe level (SLL)을 이용하였고, SLL이 가장 낮은 안테나 배열을 구하기 위한 최적화 기법으로는 입자 군집 최적화(particle-swarm optimization, PSO), 유전 알고리즘(genetic algorithm, GA), 패턴 검색 알고리즘(pattern-search algorithm, PSA) 등을 적용하였다. 128 채널의 광 안테나 배치로 이루어진 비주기적 OPA에서 위 3가지 최적화 기법을 적용하여 결과를 비교하였다. 전반적으로 PSO와 GA는 서로 유사한 최적화 결과를 보였고, PSA는 이와는 약간 차별적인 특성을 보였다. 최적화가 이루어진 각도가 45도보다 작을 때에는 최적화 각도가 작을수록 모든 조향 각도에서의 평균적인 SLL 값이 증가하는 경향을 보였지만, 최적화가 이루어진 각도가 45도 이상일 경우에는 최적화 알고리즘에 관계없이 -13 dB 이하의 평균 SLL 값을 얻을 수 있었다. 본 연구를 통해 비주기적인 OPA에서 고품질의 신호를 얻기 위한 최적의 안테나 배열을 구하는 데 있어서 PSO, GA, PSA의 최적화 알고리즘이 유용하게 활용될 수 있음을 보였다.

• 대한임상검사과학회지
• /
• 제45권1호
• /
• pp.5-8
• /
• 2013

In the specimen of free PSA in the low concentration, the result in % bias from our institution and comparable evaluation institution was -33.7% which is exceeded % bias ${\pm}20%$ ; however, it was the domestically allowable limit recommended by the laboratory accreditation commission for specimen at the low concentration. In this paper, the cause was accredited by instability of free PSA substance within the specimen, and the specimen stability test was performed according to CLSI documents GP29-A2. After the low and high concentration specimen were made, and rapidly cooled down in a deep freezer with $-30^{\circ}C$, serum of two concentrations was measured for 10 consecutive days with 3 times a day by Architect i2000 and observed a change in the mean value. As the results of two groups, there were changes in the established target value, and a change level was evaluated by calculating it with % bias. The low concentration specimen had no significant reduction until the 4 day lapse in cold storage. However, % bias were reduced by -17.5% from the 5 day lapse, by 21.5% after the 7 day lapse, and by -26.9% after the 9 day lapse. The frozen specimen had only intra-day variation for 10 days. In the high concentration specimen, bias began to show as -12.2% from the 3 day lapse in cold storage. There was reduction by -28.9% from the 5 day lapse, by -39% after the 7 day lapse, and by -42.9% after the 9 day lapse. In the frozen specimen, there was only intra-day variation like the low concentration specimen in cold storage.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권3호
• /
• pp.1259-1275
• /
• 2015

Background: This study reviewed the published evidence as to how prostate cancer outcomes vary across geographical remoteness and area level disadvantage. Materials and Methods: A review of the literature published from January 1998 to January 2014 was undertaken: Medline and CINAHL databases were searched in February to May 2014. The search terms included terms of 'Prostate cancer' and 'prostatic neoplasms' coupled with 'rural health', 'urban health', 'geographic inequalities', 'spatial', 'socioeconomic', 'disadvantage', 'health literacy' or 'health service accessibility'. Outcome specific terms were 'incidence', 'mortality', 'prevalence', 'survival', 'disease progression', 'PSA testing' or 'PSA screening', 'treatment', 'treatment complications' and 'recurrence'. A further search through internet search engines was conducted to identify any additional relevant published reports. Results: 91 papers were included in the review. While patterns were sometimes contrasting, the predominate patterns were for PSA testing to be more common in urban (5 studies out of 6) and affluent areas (2 of 2), higher prostate cancer incidence in urban (12 of 22) and affluent (18 of 20), greater risk of advanced stage prostate cancer in rural (7 of 11) and disadvantaged (8 of 9), higher survival in urban (8 of 13) and affluent (16 of 18), greater access or use of definitive treatment services in urban (6 of 9) and affluent (7 of 7), and higher prostate mortality in rural (10 of 20) and disadvantaged (8 of 16) areas. Conclusions: Future studies may need to utilise a mixed methods approach, in which the quantifiable attributes of the individuals living within areas are measured along with the characteristics of the areas themselves, but importantly include a qualitative examination of the lived experience of people within those areas. These studies should be conducted across a range of international countries using consistent measures and incorporate dialogue between clinicians, epidemiologists, policy advocates and disease control specialists.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권14호
• /
• pp.5967-5970
• /
• 2015

Background: The prevalence of prostate cancer is considered high in many countries, and screening tests are very important in order to detect prostate cancer in its early stages; however false positivity with these screening tests means that a lot of patients undergo unnecessary biopsy, which is an invasive procedure, for the confirmatory test. The purpose of this study was to estimate the frequency of unnecessary biopsy cases in patients referred for prostate biopsy in one of the most important and overload cancer centers in Syria. Materials and Methods: Retrospective data for a period of four years between January 2009 and December 2012 were collected in Al-Bayrouni University Medical hospital in Damascus, Syria. The patients from whom data were collected were referred to our histopathological department because of elevated prostate specific antigen (PSA) serum or an abnormal digital rectal examination (DRE). All patients underwent prostatic TRUS-guided biopsies. Diagnosis of prostate cancer (PCa) or benign prostatic hyperplasia (BPH) was based on histopathological examination and prostate cancers cases were graded and scored according to the Gleason score system. Results: For the 406 patients referred to biopsy, the $mean{\pm}SD$ age was $58.4{\pm}23.3$ years. The $mean{\pm}SD$ PSA level was $49.2{\pm}21.5ng/ml$. Of the total we found 237 patients diagnosed with PCa (58. 4%), 166 patients with BPH (40.9%) and 3 cases were unable to be diagnosed (0.7%) because of biopsy collection errors. Conclusions: Our study shows that a high percentage of patients are undergoing unnecessary biopsy, which suggests that the performed screening tests had a high level of false positive and may need re-evaluation.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권9호
• /
• pp.3969-3972
• /
• 2015

Background: This analysis was conducted to evaluate the efficacy and safety of lenalidomide based regimen in treating patients with castration-resistant prostate cancer. Materials and Methods: Clinical studies evaluating the efficacy and safety of lenalidomide based regimens on response and safety for patients with castration-resistant prostate cancer were identified using a predefined search strategy. A pooled response rate (rate of PSA level decline of ${\geq}50%$) to treatment was calculated. Results: In lenalidomide based regimen, 3 clinical studies which including 98 patients with castration-resistant prostate cancer were considered eligible for inclusion. These lenalidomide based regimens included cisplatin, doxorubicin, or GM-CSF. Pooled analysis suggested that, in all patients, the pooled PSA level decline of ${\geq}50%$ was 13.3% (13/98) in lenalidomide based regimens. Fatigue, nausea and vomitting were the main side effects. No grade III or IV renal or liver toxicity were observed. No treatment related death occurred in patients with lenalidomide based regimens. Conclusions: This evidence based analysis suggests that lenalidomide based regimens are associated with mild response rate and acceptable toxicities for treating patients with castration-resistant prostate cancer.

• 한국안전학회지
• /
• 제26권5호
• /
• pp.105-109
• /
• 2011

Since a severe accident, which happens in low frequency, can cause serious damages, the interests in off-site consequence analysis for a nuclear power plant have been increased after Chernobyl, TMI and Fukushima accidents. Consequences, which are the effects on health and environment caused by released radioisotopes, are evaluated using MACCS II code based on the method of Level 3 PSA. To perform a consequence analysis for the reference plants, the input data of the code were generated such as meteorological data, population distribution, release fractions, and so on. Using these input data, acute and lifetime dose as an organ, CCDF for early fatalities and latent cancer fatalities, and average individual risk were analyzed by using MACCS II code in this study. These results might contribute to establishing accident management plan and quantitative health object.